Assessment of low-density lipoprotein oxidation, paraoxonase activity, and arterial distensibility in epileptic children who were treated with anti-epileptic drugs

Cardiology in the Young

Volumn 20, Issue 5, 2010, Pages 547-554

  Yildiz, Mustafa ^a   Simsek, Gonul ^a   Uzun, Hafize ^a   Uysal, Serap ^b   Sahin, Sevim ^b   Balci, Huriye ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

arterial distensibility; Carbamazepine; oxidised low density lipoprotein; paraoxanase; valproic acid

Indexed keywords

APOLIPOPROTEIN A1; ARYLDIALKYLPHOSPHATASE; CARBAMAZEPINE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; LIPID; MALONALDEHYDE; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; THYROID HORMONE; THYROTROPIN; THYROXINE; VALPROIC ACID;

ADOLESCENT; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; ATHEROGENESIS; CAROTID ARTERY PULSE; CHILD; DRUG BLOOD LEVEL; DRUG EFFECT; ENZYME ACTIVITY; EPILEPSY; FEMALE; FEMORAL ARTERY FLOW; HUMAN; HUMAN CELL; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; PULSE WAVE; THYROXINE BLOOD LEVEL;

ADOLESCENT; ANTICONVULSANTS; ARYLDIALKYLPHOSPHATASE; ATHEROSCLEROSIS; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIPOPROTEINS, LDL; MALE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; VASCULAR RESISTANCE;

EID: 78649932246     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951110000697     Document Type: Article

References (38)

1. Verrotti A, Domizio S, Angelozzi B, Sabatino G, Morgese G, Chiarelli F. Changes in serum lipids and lipoproteins in epileptic children treated with anticonvulsants. J Paediatr Child Health 1997; 33: 242-245.
2. Karabiber H, Sonmezgoz E, Ozerol E, Yakinci C, Otlu B, Yologlu S. Effects of valproate and carbamazepine on serum levels of homocysteine, vitamin B12, and folic acid. Brain Dev 1997; 25: 113-115.
3. Li D, Mehta JL. Oxidized LDL, a critical factor in atherogenesis. Cardiovasc Res 2005; 68: 353-354.
4. Rodríguez Esparragón F, Hernández Trujillo Y, Macías Reyes A, Hernández Ortega E, Medina A, Rodríguez Pérez JC. Concerning the significance of paraoxonase-1 and SR-B1 genes in atherosclerosis. Rev Esp Cardiol 2006; 59: 154-164.
5. Asmar R, Benetos A, Topouchian J, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995; 26: 485-490.
6. Saha N, Roy AC, Teo SH, Tay JS, Ratnam SS. Influence of serum paraoxonase polymorphism on serum lipids and apolipoproteins. Clin Genet 1991; 40: 277-282.
7. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978; 12: 302-310.
8. Mackness B, Durrington PN, Mackness MI. Human serum paraoxonase. Gen Pharm 1998; 3: 329-336.
9. Ikeda Y, Suehiro T, Itahara T, et al. Human serum paraoxonase concentration predicts cardiovascular mortality in hemodialysis patients. Clin Nephrol 2007; 67: 358-365.
10. Cabana VG, Reardon CA, Feng N, Neath S, Lukens J, Getz GS. Serum paraoxonase: Effect of the apolipoprotein composition of HDL and the acute phase response. J Lipid Res 2003; 44: 780-792.
11. Reddy MN. Effect of anticonvulsant drugs on plasma total cholesterol, high-density lipoprotein cholesterol, and apolipoproteins A and B in children with epilepsy. Proc Soc Exp Biol Med 1985; 180: 359-363.
12. Dagre AG, Lekakis JP, Papaioannou TG, et al. Arterial stiffness is increased in subjects with hypothyroidism. Int J Cardiol 2005; 103: 1-6.
13. Isojärvi JIT, Turkka J, Pakarinen AJ, Kotila M, Rättyä J, Myllylä VV. Thyroid function in men taking carbamazepine, oxcarbazepine, or valproate for epilepsy. Epilepsia 2001; 42: 930-934.
14. Villa SM, Alexander NM. Carbamazepine (Tegretol) inhibits in vivo iodide uptake and hormone synthesis in rat thyroid glands. Endocr Res 1987; 13: 385-397.
15. Aanderud S, Strandjord RE. Hypothyroidism induced by antiepileptic therapy. Acta Neurol Scand 1980; 61: 330-332.
16. Hegedü s L, Hansen M, Lühdorf K, Perrild H, Feldt-Rasmussen U, Kampmann JP. Increased frequency of goitre in epileptic patients on long-term phenytoin or carbamazepine treatment. Clin Endocrinol 1985; 23: 423-429.
17. Wilkinson IB, Cockcroft JR. Mind the gap: Pulse pressure, cardiovascular risk, and isolated systolic hypertension. Am J Hypertens 2000; 13: 1315-1317.
18. Ojamaa K, Balkman C, Klein I. Acute effects of thyroid hormone on vascular smooth muscle. Thyroid 1996; 6: 505-512.
19. Mizuma H, Murakami M, Mori M. Thyroid hormone activation in human vascular smooth muscle cells; expression of type II deiodinase activity. Circ Res 2001; 88: 313-318.
20. Bengel FM, Nekolla SG, Ibrahim T, Weniger C, Ziegler SI, Schwaiger M. Effect of thyroid hormones on cardiac function, geometry, and oxidative metabolism assessed noninvasively by positron emission tomography and magnetic resonance imaging. J Clin Endocrinol Metab 2000; 85: 1822-1827.
21. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004; 109 (Suppl 1): III27-III32.
22. Akinci B, Comlekci A, Yener S, et al. The alteration of serum soluble CD40 ligand levels in overt and subclinical hypothyroidism. Hormones (Athens) 2007; 6: 327-333.
23. Orzechowska-Pawilojc A, Sworczak K, Lewczuk A, Babinska A. Homocysteine, folate and cobalamin levels in hypothyroid women before and after treatment. Endocr J 2007; 54: 471-476.
24. Ozmen B, Ozmen D, Parildar Z, Mutaf I, Turgan N, Bayindir O. Impact of renal function or folate status on altered plasma homocysteine levels in hypothyroidism. Endocr J 2006; 53: 119-124.
25. Hanna AN, Feller DR, Witiak DT, Newman HA. Inhibition of low density lipoprotein oxidation by thyronines and probuclo. Biochem Pharmacol 1993; 45: 753-762.
26. Squizzato A, Gerdes VE, Brandjes DP, Bü ller HR, Stam J. Thyroid diseases and cerebrovascular disease. Stroke 2005; 36: 2302-2310.
27. Crisp MS, Lane C, Halliwell M, Wynford-Thomas D, Ludgate M. Thyrotropin receptor transcripts in human adipose tissue. J Clin Endocrinol Metab 1997; 82: 2003-2005.
28. Powell J, Zadeh JA, Carter G, Greenhalgh RM, Fowler PB. Raised serum thyrotrophin in women with peripheral arterial disease. Br J Surg 1987; 74: 1139-1141.
29. Nanda N, Bobby Z, Hamide A. Association of thyroid stimulating hormone and coronary lipid risk factors with lipid peroxidation in hypothyroidism. Clin Chem Lab Med 2008; 46: 674-679.
30. Duntas LH, Mantzou E, Koutras DA. Circulating levels of oxidized low-density lipoprotein in overt and mild hypothyroidism. Thyroid 2002; 12: 1003-1007.
31. Duman D, Demirtunc R, Sahin S, Esertas K. The effects of simvastatin and levothyroxine on intima-media thickness of the carotid artery in female normolipemic patients with subclinical hypothyroidism: A prospective, randomized-controlled study. J Cardiovasc Med (Hagerstown) 2007; 8: 1007-1011.
32. Coria MJ, Pastrán AI, Gimenez MS. Serum oxidative stress parameters of women with hypothyroidism. Acta Biomed 2009; 80: 135-139.
33. Azizi F, Raiszadeh F, Solati M. Serum paraoxonase 1 activity is decreased in thyroid dysfunction. J Endocrinol Invest 2003; 26: 703-709.
34. Baskol G, Atmaca H, Tanriverdi F, Baskol M, Kocer D, Bayram F. Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment. Exp Clin Endocrinol Diabetes 2007; 115: 522-526.
35. Yavuz DG, Yü ksel M, Deyneli O, Ozen Y, Aydin H, Akalin S. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients. Clin Endocrinol (Oxf) 2004; 61: 515-521.
36. Młodzikowska-Albrecht J, Steinborn B, Zarowski M. Cytokines, epilepsy and epileptic drugs - is there a mutual influence? Pharmacol Rep 2007; 59: 129-138.
37. Shiah IS, Yatham LN, Yeh CB, Ravindran AV. Effect of valproate on plasma levels of interleukin-6 in healthy male humans. Int Clin Psychopharmacol 2005; 20: 295-298.
38. Verrotti A, Basciani F, Trotta D, Greco R, Morgese G, Chiarelli F. Effect of anticonvulsant drugs on interleukins-1, -2 and -6 and monocyte chemoattractant protein-1. Clin Exp Med 2001; 1: 133-136.